(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMERICA'S BIOPHARMACEUTICAL COMPANIES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

AMERICA'S BIOPHARMACEUTICAL COMPANIES

ST13

US500000087347024

Class

9, 35, 41, 42

Filing

87347024

Registration

6329053

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

60

Latest update

04/21/2026

Classification

Registered

Trademark type

Combined

Nice classes

9, 35, 41, 42

Filing date

02/23/2017

Registration date

04/20/2021

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/20/2021

Last transaction

04/21/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2017-01-00

First use in commerce

2017-01-00

Drawing code

3

Owner type

03

Owner location

Washington, DC, US

Examiner

AWRICH, ELLEN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the white stylized wording "AMERICA'S BIOPHARMACEUTICAL COMPANIES" to the right of a rectangular pattern formed by three rows of tiles of varying lengths. The tiles in the top row are, from left to right, a forest green rectangle and an apple green rectangle. The tiles in the middle row are, from left to right, a kelly green rectangle, a forest green rectangle, and a yellow rectangle. The tiles in the bottom row are, from left to right, an apple green square, a teal rectangle, and a mint green rectangle. The black is not part of the mark and represents background area.

Holders and representatives

Holders

P. A. (pessoa física)

Representatives

B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Technical classification

Nice Classes

Class 9Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Electronic downloadable publications in the nature of fact sheetsreportsinfographics regarding biopharmaceuticals and the biopharmaceutical industry

Class 35

Association servicespromoting the interests of research-based prescription drug manufacturers

Class 41

Providing a website featuring non-downloadable publications in the nature of testimonialsinfographicsfact sheetsreportsarticlesvideos regarding biopharmaceuticals and the biopharmaceutical industry

Class 42

Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing

Publications

History of USPTO decisions and trademark events.

60 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/20/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/07/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/07/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/07/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/07/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/07/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/20/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/16/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/15/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/11/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/11/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/05/2021

GNRT

NON-FINAL ACTION E-MAILED

03/05/2021

CNRT

SU - NON-FINAL ACTION - WRITTEN

03/05/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/04/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/04/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/22/2021

GNRT

NON-FINAL ACTION E-MAILED

02/22/2021

CNRT

SU - NON-FINAL ACTION - WRITTEN

02/22/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/22/2021

IUAF

USE AMENDMENT FILED

02/19/2021

EISU

TEAS STATEMENT OF USE RECEIVED

02/19/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/11/2020

EX5G

SOU EXTENSION 5 GRANTED

08/09/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/09/2020

EXT5

SOU EXTENSION 5 FILED

07/22/2020

EEXT

SOU TEAS EXTENSION RECEIVED

07/22/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/13/2020

EX4G

SOU EXTENSION 4 GRANTED

02/11/2020

EXT4

SOU EXTENSION 4 FILED

02/11/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/11/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/20/2019

EX3G

SOU EXTENSION 3 GRANTED

08/16/2019

EXT3

SOU EXTENSION 3 FILED

08/16/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/16/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/07/2019

EX2G

SOU EXTENSION 2 GRANTED

02/05/2019

EXT2

SOU EXTENSION 2 FILED

02/05/2019

EEXT

SOU TEAS EXTENSION RECEIVED

02/05/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/13/2018

EX1G

SOU EXTENSION 1 GRANTED

07/11/2018

EXT1

SOU EXTENSION 1 FILED

07/11/2018

EEXT

SOU TEAS EXTENSION RECEIVED

07/11/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/20/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/26/2017

PUBO

PUBLISHED FOR OPPOSITION

12/26/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/06/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/15/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/14/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/13/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/13/2017

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

05/23/2017

GPRA

PRIORITY ACTION E-MAILED

05/23/2017

CPRA

PRIORITY ACTION WRITTEN

05/23/2017

DOCK

ASSIGNED TO EXAMINER

05/18/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/03/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/02/2017

NWAP

NEW APPLICATION ENTERED

02/27/2017

Continuous trademark protection

Get notified about every new filing that threatens AMERICA'S BIOPHARMACEUTICAL COMPANIES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.